CoChat

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling

Clouet-Foraison, Noémie, Gaie-Levrel, Francois, Gillery, Philippe, Delatour, Vincent · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract

With the increasing prevalence of cardiovascular diseases (CVD) worldwide, finding reliable and clinically relevant biomarkers to predict acute cardiovascular events has been a major aim of the scientific and medical community. Improvements of the understanding of the pathophysiological pathways of the disease highlighted the major role of lipoprotein particles, and these past decades have seen the emergence of a number of new methodologies to separate, measure and quantitate lipoproteins. Those methods, also known as advanced lipoprotein testing methods (ALT), have gained acceptance in the field of CVD risk assessment and have proven their clinical relevance. In the context of worldwide standardization and harmonization of biological assays, efforts have been initiated toward standardization of ALT methods. However, the complexity of lipoprotein particles and the multiple approaches and methodologies reported to quantify them have rendered these initiatives a critical issue. In this context and to better understand these challenges, this review presents a summary of the major methods available for ALT with the aim to point out the major differences in terms of procedures and quantities actually measured and to discuss the resulting comparability issues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm-2017-0091

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Research works printed but not linked: 103

  1. 2010, Ion mobility analysis of lipoproteins
  2. 1999, Analysis of apolipoproteins and lipoproteins by capillary electrophoresis, Electrophoresis, 2, 2118
  3. 2000, Handbook of lipoprotein testing, 1
  4. 2014, Development and evaluation of a novel advanced lipoprotein test based on 2D diffusion ordered 1H-NMR spectroscopy [thesis]
  5. 2000, Handbook of lipoprotein testing, 625
  6. 1992, Analysis for cholesterol in all lipoprotein classes by single vertical ultracentrifugation of fingerstick blood and controlled-dispersion flow analysis, Clin Chem, 38, 1898, 10.1093/clinchem/38.9.1898 · DOI
  7. 1955, The distribution and chemical composition of Ultracentrifugally separated lipoproteins in human serum, J Clin Invest, 34, 1345, 10.1172/JCI103182 · DOI · Paper page
  8. 2014, Accurate serum apolipoprotein A-I and B measurement using the agilent 1290 infinity LC and 6490 triple quadrupole LC/MS system, Agilent Application Note, 1
  9. 2014, Development and evaluation of a novel advanced lipoprotein test based on 2D diffusion ordered 1H-NMR spectroscopy [thesis]
  10. 2000, Handbook of lipoprotein testing, 625
  11. 1994, Effects of orientational order and particle size on the NMR line positions of lipoproteins, Phys Rev Lett, 72, 4049, 10.1103/PhysRevLett.72.4049 · DOI
  12. 2012, Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?, J Am Coll Cardiol, 60, 2616, 10.1016/j.jacc.2012.06.065 · DOI
  13. 2000, Handbook of Lipoprotein Testing, 609
  14. 1991, An ultrafine aerosol condensation nucleus counter, Aerosol Sci Technol, 14, 48, 10.1080/02786829108959470 · DOI · Paper page
  15. 2008, Apo B measurement system and method. WO 2008130686 A1
  16. 2017, Biomarkers for cardiovascular screening: progress or passé?, Clin Chem, 63, 248, 10.1373/clinchem.2016.254854 · DOI
  17. 1996, Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women, J Am Med Assoc, 276, 875, 10.1001/jama.1996.03540110029028 · DOI · Paper page
  18. 2009, Apolipoprotein B and cardiovascular disease risk: position statement from the AACC lipoproteins and vascular diseases division working group on best practices, Clin Chem, 55, 407, 10.1373/clinchem.2008.118356 · DOI · Paper page
  19. 2015, Method for analyzing lipoproteins
  20. 2000, Handbook of lipoprotein testing, 287
  21. 2011, Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists, J Clin Lipidol, 5, 338, 10.1016/j.jacl.2011.07.005 · DOI · Paper page
  22. 2012, Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy, Anal Bioanal Chem, 402, 2407, 10.1007/s00216-011-5705-9 · DOI
  23. 2015, Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis, Atherosclerosis, 242, 496, 10.1016/j.atherosclerosis.2015.08.021 · DOI · Paper page
  24. 2010, The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum, Rapid Commun Mass Spectrom, 21, 2585
  25. 1991, Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy, Clin Chem, 37, 377, 10.1093/clinchem/37.3.377 · DOI · Paper page
  26. 2000, Handbook of lipoprotein testing, 593
  27. 1995, Advances in agarose gel electrophoresis of serum lipoproteins, J Chromatogr A, 698, 333, 10.1016/0021-9673(94)01192-H · DOI
  28. 1995, Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology, J Lipid Res, 36, 2291, 10.1016/S0022-2275(20)39710-8 · DOI
  29. 2015, Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?, Atherosclerosis, 242, 399, 10.1016/j.atherosclerosis.2015.07.040 · DOI
  30. 2006, Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics, Clin Chem, 52, 1722, 10.1373/clinchem.2005.059949 · DOI
  31. 2012, Electrospray-differential mobility analysis of bionanoparticles, Trends Biotechnol, 30, 291, 10.1016/j.tibtech.2012.02.003 · DOI
  32. 2006, Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy, Clin Lab Med, 26, 847, 10.1016/j.cll.2006.07.006 · DOI · Paper page
  33. 2014, Advanced lipoprotein testing: strengths and limitations [Internet]
  34. 2010, Lipoprotein(a) as a cardiovascular risk factor: current status, Eur Heart J, 31, 2844, 10.1093/eurheartj/ehq386 · DOI · Paper page
  35. 2010, Ion mobility analysis of lipoproteins
  36. 2015, Method for the characterization of lipoproteins. WO 2015 079000 A1
  37. 2008, Apo B measurement system and method. WO 2008130686 A1
  38. 1989, Measurement of proteins with the Behring nephelometer – a multicentre evaluation, Clin Chem Lab Med, 27, 261
  39. 2000, Handbook of lipoprotein testing, 287
  40. 2015, Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy, J Lipid Res, 56, 737, 10.1194/jlr.D050120 · DOI · Paper page
  41. 1992, International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials, Clin Chem, 38, 658, 10.1093/clinchem/38.5.658 · DOI
  42. 1986, High-performance liquid chromatography of serum lipoproteins, Methods Enzymol, 129, 57, 10.1016/0076-6879(86)29062-X · DOI
  43. 1995, Isotope dilution mass spectrometry as a candidate definitive method for determining total glycerides and triglycerides in serum, Clin Chem, 41, 397, 10.1093/clinchem/41.3.397 · DOI
  44. 2011, A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk, Circ Cardiovasc Qual Outcomes, 4, 337, 10.1161/CIRCOUTCOMES.110.959247 · DOI · Paper page
  45. 2000, Handbook of lipoprotein testing, 1
  46. 2011, Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial), Am J Cardiol, 108, 40, 10.1016/j.amjcard.2011.03.003 · DOI · Paper page
  47. 2014, NMR measurement of LDL particle number using the Vantera clinical analyzer, Clin Biochem, 47, 203, 10.1016/j.clinbiochem.2014.07.015 · DOI · Paper page
  48. 1980, Rapid analysis of cholesterol of high density lipoprotein and low density lipoprotein in human serum by high performance liquid chromatography, J Biochem, 87, 1863, 10.1093/oxfordjournals.jbchem.a132933 · DOI
  49. 2011, Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple-reaction-monitoring mass spectrometry, Clin Chem, 56, 1804
  50. 2013, Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?, Clin Chem, 59, 723, 10.1373/clinchem.2013.203208 · DOI
  51. 2016, Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays, Clin Chem, 62, 48, 10.1373/clinchem.2015.250563 · DOI · Paper page
  52. 2012, Small dense LDL: an emerging risk factor for cardiovascular disease, Clin Chim Acta, 414, 215, 10.1016/j.cca.2012.09.010 · DOI · Paper page
  53. 2000, A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples, J Lipid Res, 41, 1020, 10.1016/S0022-2275(20)32045-9 · DOI
  54. 2016, Recent advances in analytical methods on lipoprotein subclasses: calculation of particle numbers from lipid levels by gel permeation HPLC using “spherical particle model”, J Oleo Sci, 65, 265, 10.5650/jos.ess16020 · DOI
  55. 2000, Handbook of Lipoprotein Testing, 609
  56. 1993, Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins, Clin Chem, 39, 2276, 10.1093/clinchem/39.11.2276 · DOI
  57. 2001, Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix lipoprint LDL system, Clin Chem, 47, 266, 10.1093/clinchem/47.2.266 · DOI · Paper page
  58. 2000, Assessment of between-instrument variations in a HPLC method for serum lipoproteins and its traceability to reference methods for total cholesterol and HDL-cholesterol, Clin Chem, 46, 63, 10.1093/clinchem/46.1.63 · DOI
  59. 2011, Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins, Metabolomics, 7, 572, 10.1007/s11306-011-0273-8 · DOI
  60. 1986, Single vertical spin density gradient ultracentrifugation, Methods Enzymol, 128, 181, 10.1016/0076-6879(86)28068-4 · DOI · Paper page
  61. 2002, Reference materials for the standardization of the apolipoproteins A-I and B and lipoprotein(a) [Internet], e-Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 13
  62. 2013, Size characterization of airborne SiO2 nanoparticles with on-line and off-line measurement techniques: an interlaboratory comparison study, J Nanoparticle Res, 15, 1919, 10.1007/s11051-013-1919-4 · DOI
  63. 1990, Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk, Circulation, 82, 495, 10.1161/01.CIR.82.2.495 · DOI · Paper page
  64. 2014, Advanced lipoprotein testing: strengths and limitations [Internet]
  65. 2011, Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis, Lipids, 46, 1163, 10.1007/s11745-011-3611-8 · DOI
  66. 2015, Method for the characterization of lipoproteins. WO 2015 079000 A1
  67. 2014, Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin), Circulation, 129, 635, 10.1161/CIRCULATIONAHA.113.004406 · DOI · Paper page
  68. 2000, Handbook of lipoprotein testing, 593
  69. 2014, Accurate serum apolipoprotein A-I and B measurement using the agilent 1290 infinity LC and 6490 triple quadrupole LC/MS system, Agilent Application Note, 1
  70. 1998, Analysis of biomolecules using electrospray and nanoparticle methods: the gas-phase electrophoretic mobility molecular analyzer (GEMMA), J Aerosol Sci, 29, 537, 10.1016/S0021-8502(97)00462-X · DOI
  71. 2015, Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the JUPITER Trial, Circulation, 132, 2220, 10.1161/CIRCULATIONAHA.115.016857 · DOI · Paper page
  72. 2002, Reference materials for the standardization of the apolipoproteins A-I and B and lipoprotein(a) [Internet], e-Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 13
  73. 1969, Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugation, Lipids, 4, 55, 10.1007/BF02531795 · DOI
  74. 1999, Analysis of apolipoproteins and lipoproteins by capillary electrophoresis, Electrophoresis, 2, 2118
  75. 2012, Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the treating to new targets (TNT) study, Circulation, 125, 1979, 10.1161/CIRCULATIONAHA.111.088591 · DOI · Paper page
  76. 1981, High-resolution plasma-lipoprotein cholesterol profiles by a rapid, high volume semi-automated method, J Lipid Res, 22, 1003, 10.1016/S0022-2275(20)37338-7 · DOI
  77. 1995, Chromatographic techniques for the isolation and purification of lipoproteins, J Chromatogr B Biomed Appl, 671, 237, 10.1016/0378-4347(95)00051-J · DOI
  78. 2009, Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk, Arterioscler Thromb Vasc Biol, 29, 1975, 10.1161/ATVBAHA.109.190405 · DOI · Paper page
  79. 2000, Handbook of lipoprotein testing, 647
  80. 2012, What is the role of advanced lipoprotein analysis in practice?, J Am Coll Cardiol, 60, 2607, 10.1016/j.jacc.2012.04.067 · DOI
  81. 2014, Quantification of HDL particle concentration by calibrated ion mobility analysis, Clin Chem, 60, 1393, 10.1373/clinchem.2014.228114 · DOI
  82. 1982, Computerized rapid high resolution quantitative analysis of plasma lipoproteins based upon single vertical spin centrifugation, J Lipid Res, 23, 923, 10.1016/S0022-2275(20)38096-2 · DOI
  83. 1989, Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100, J Lipid Res, 30, 1445, 10.1016/S0022-2275(20)38265-1 · DOI
  84. 1990, Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography, J Chromatogr B Biomed Appl, 525, 433, 10.1016/S0378-4347(00)83420-9 · DOI
  85. 2013, LipoSEARCH ® Analytical GP-HPLC method for lipoprotein profiling and its applications, J Biol Macromol, 13, 21, 10.14533/jbm.13.21 · DOI
  86. 1997, Analytical capillary isotachophoresis of human serum lipoproteins, Electrophoresis, 18, 1807, 10.1002/elps.1150181015 · DOI
  87. 2010, Lipoprotein particle profiles by NMR compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women, Circulation, 119, 931
  88. 1996, Isotope-dilution mass spectrometric quantification of specific proteins: model application with apolipoprotein A-1, Clin Chem, 42, 1676, 10.1093/clinchem/42.10.1676 · DOI · Paper page
  89. 1990, Immunological assays of apolipoproteins in plasma: methods and instrumentation, Clin Chem, 36, 591, 10.1093/clinchem/36.4.591 · DOI
  90. 2015, Method for analyzing lipoproteins
  91. 2014, 2013 ACC/AHA Guideline on the assessment of cardiovascular risk – a report of the American College of Cardiology/American Heart Association task force on practice guidelines, J Am Coll Cardiol, 63, 2935
  92. 1994, Quantification of cholesterol in all lipoprotein classes by the VAP-II method, J Lipid Res, 35, 159, 10.1016/S0022-2275(20)40123-3 · DOI
  93. 2007, LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA), Atherosclerosis, 192, 211, 10.1016/j.atherosclerosis.2006.05.007 · DOI · Paper page
  94. 2006, Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies, J Intern Med, 259, 481, 10.1111/j.1365-2796.2006.01644.x · DOI · Paper page
  95. 2000, Handbook of lipoprotein testing, 647
  96. 1968, Electrophoretic separation of plasma lipoproteins in agarose gel, J Lipid Res, 9, 693, 10.1016/S0022-2275(20)42680-X · DOI · Paper page
  97. 2007, Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet, 370, 1829, 10.1016/S0140-6736(07)61778-4 · DOI · Paper page
  98. 2017, On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins, J Proteomics, 150, 258, 10.1016/j.jprot.2016.09.011 · DOI · Paper page
  99. 1981, High performance aqueous gel permeation chromatography of serum lipoproteins: selective detection of cholesterol by enzymatic reaction, J Chromatogr – Biomed Appl, 223, 285, 10.1016/S0378-4347(00)80100-0 · DOI
  100. 2017, Absolute quantification of bio-nanoparticles by electrospray differential mobility analysis: an application to lipoprotein particle concentration measurements, Anal Chem, 89, 2242, 10.1021/acs.analchem.6b02909 · DOI
  101. 2006, Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial, Circulation, 113, 1556, 10.1161/CIRCULATIONAHA.105.565135 · DOI · Paper page
  102. 2013, Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC lipoprotein and vascular diseases division working group on best practices, Clin Chem, 59, 752, 10.1373/clinchem.2012.196733 · DOI · Paper page
  103. 2008, Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis, Clin Chem, 54, 1307, 10.1373/clinchem.2007.100586 · DOI · Paper page

Cited by

See all 30

Metadata

Authors
Clouet-Foraison, N., Gaie-Levrel, F., Gillery, P., & Delatour, V.
Affiliations
  • Laboratoire National de Métrologie et d'Essais (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Delatour, Vincent
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2017-01-01
Volume
55
Issue
10
Pages
1453-1464
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W2613798300
Cited by
30
References
81
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 3
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
cardiovascular disease risk assessment, cardiovascular biomarkers, lipoprotein quantification, method standardization, assay comparability, lipoprotein particles
MeSH terms
Cardiovascular Diseases, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Humans, Immunoassay, Lipoproteins, Magnetic Resonance Spectroscopy, Mass Spectrometry, Biomarkers, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling. https://app.cochat.ai/papers/10.1515/cclm-2017-0091
The paper
Clouet-Foraison, N., Gaie-Levrel, F., Gillery, P., & Delatour, V. (2017). Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2017-0091

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.